Register for an account

X

Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.

X

Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.

Technology

Swallow This: New Electronic iPill Delivers Drugs On Command

80beatsBy Nina BaiNovember 13, 2008 5:38 AM

Newsletter

Sign up for our email newsletter for the latest science news

ipill.jpg

A new intelligent pill designed by Philips, the Dutch electronics company, promises to deliver medicine in the right place, at the right time, inside your body. The company, best known for consumer products like webcams and wireless headphones, is packing some of the same technology into the new pill, known as the iPill.

Containing a microprocessor, battery, wireless radio, pump and a reservoir for medication, the inch-long capsule is designed to treat digestive tract disorders such as Crohn’s disease and ulcerative colitis [Times Online].

Once swallowed, the iPill allows researchers to keep track of its precise location through a wireless transmitter. It sends dispatches about the temperature and acidity of its surroundings to an outside receiver as it travels through the GI tract over the course of a day or two. The acidity, measured by pH, of the gut decreases as the pill gets further from the stomach, and that allows researchers to pinpoint the place where the drug is needed [San Francisco Chronicle].

Researchers can pre-program drug release when certain conditions are met or cue the drug release using a remote controller.

Similar robotic capsules with built-in cameras have been developed for colon endoscopy, but the iPill is the first to have drug delivering capabilities. Targeting drugs

directly to the location of the disease means doses can be lower, reducing side effects, Philips said [Reuters].

For now, the iPill is still in prototype stage and the company plans to first market the pills to pharmaceutical companies for as much as $1,000 per pill. If the iPill becomes commonplace, the cost would go down significantly. If the iPill becomes, say, as ubiquitous as the iPod,

Philips senior scientist Jeff Shimizu can think of one possible problem:

Keeping the minute devices out of our water supply. To do so, sewage treatment plants might someday have to screen for iPills, he said. "If we're selling millions of them, it could be an issue." [San Francisco Chronicle].

Related Content: DISCOVER: Surgery in Cyberspace DISCOVER: Robodoc DISCOVER: End of the NeedleImage: Philips

3 Free Articles Left

Want it all? Get unlimited access when you subscribe.

Subscribe

Already a subscriber? Register or Log In

Want unlimited access?

Subscribe today and save 70%

Subscribe

Already a subscriber? Register or Log In